This week we are hosting our annual MedCity INVEST conference online. Today’s agenda includes a panel discussion on investment trends and the biopharma track of the Pitch Perfect contest. The conference kicked off July 20 and concludes on Friday July 24. You can check out the agenda here.

At 12:30 pm today, a panel of traditional and strategic investors will share perspectives on investment trends and strategies in health tech and life sciences amidst the coronavirus.

Moderated by , BlueCross Blue Shield of Kansas Director, New Ventures Initiative, the speakers include:

, Maverick Ventures Managing Director
, Flare Capital Partners Partner
, Advocate Aurora Health VP, Corporate Ventures and Innovation,
, Cultivation Capital Principal, Life Sciences Funds I & II

At 3:30pm, biopharma startups will grab the spotlight and field questions about their technology from a team of investor judges. Those five companies include:

Biolife4D is applying 3D bioprinting to developing a patient-specific, fully functioning heart with the patient’s own cells, eliminating the challenges of organ rejection and long donor waiting lists that plague existing organ                              transplant methods.

CEO: Steven Morris

Headquarters: Buffalo Grove, IL

Libera Bio is applying decades of research in nanomedicine to deliver whole antibodies to previously “undruggable” intracellular cancer targets, starting with Kirsten rat sarcoma viral oncogene homolog (KRAS). This mutation is found in up to 25% of all human tumors.

CEO: Olivier Jarry

Headquarters: US and Spain

Moonlight Therapeutics is a pre-clinical stage biopharmaceutical company developing an immunotherapy for food allergies.

CEO: Samir Patel

Headquarters: Atlanta, GA

Pleiogenix is a clinical-stage bio-pharmaceutical company seeking to develop the next generation treatment for non-alcoholic steatohepatitis (NASH) / fibrosis.

CEO: Joseph Evans

Headquarters: Carlsbad, CA

Temprian Therapeutics is a pharmaceutical startup company operating out of the MATTER incubator in Chicago. It is focusing on drug development targeting autoimmune disease. The primary indication of its TT01 drug is vitiligo.

CEO: Kettil Cedercreutz

 Headquarters: Chicago, IL

Check out participants in the Pitch Perfect competition here.

Each day of the week will feature a pitch competition highlighting five startups in these tracks – Health Services, Health IT, Medical Devices, Biopharma and Diagnostics. Presenters will highlight their vision for changing healthcare followed up by a Q&A with investor judges. Winners for each track will be announced on July 27 on our website.

All the sessions will be recorded and be available to attendees upon request.

For questions about the event, please contact events director Laura Kittredge: lkittredge@breakingmedia.com

Picture: NicoElNino, Getty Images